{"pmid":32505074,"title":"The use of aspirated consonants during speech may increase the transmission of COVID-19.","text":["The use of aspirated consonants during speech may increase the transmission of COVID-19.","Med Hypotheses","Georgiou, Georgios P","Kilani, Ahmad","32505074"],"journal":"Med Hypotheses","authors":["Georgiou, Georgios P","Kilani, Ahmad"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32505074","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.mehy.2020.109937","topics":["Prevention","Transmission"],"weight":1,"_version_":1668892488241250306,"score":9.490897,"similar":[{"pmid":32404416,"title":"The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission.","text":["The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission.","Speech droplets generated by asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are increasingly considered to be a likely mode of disease transmission. Highly sensitive laser light scattering observations have revealed that loud speech can emit thousands of oral fluid droplets per second. In a closed, stagnant air environment, they disappear from the window of view with time constants in the range of 8 to 14 min, which corresponds to droplet nuclei of ca. 4 mum diameter, or 12- to 21-mum droplets prior to dehydration. These observations confirm that there is a substantial probability that normal speaking causes airborne virus transmission in confined environments.","Proc Natl Acad Sci U S A","Stadnytskyi, Valentyn","Bax, Christina E","Bax, Adriaan","Anfinrud, Philip","32404416"],"abstract":["Speech droplets generated by asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are increasingly considered to be a likely mode of disease transmission. Highly sensitive laser light scattering observations have revealed that loud speech can emit thousands of oral fluid droplets per second. In a closed, stagnant air environment, they disappear from the window of view with time constants in the range of 8 to 14 min, which corresponds to droplet nuclei of ca. 4 mum diameter, or 12- to 21-mum droplets prior to dehydration. These observations confirm that there is a substantial probability that normal speaking causes airborne virus transmission in confined environments."],"journal":"Proc Natl Acad Sci U S A","authors":["Stadnytskyi, Valentyn","Bax, Christina E","Bax, Adriaan","Anfinrud, Philip"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404416","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1073/pnas.2006874117","keywords":["covid-19","disease transmission","independent action hypothesis","respiratory disease","speech droplet"],"topics":["Prevention","Transmission"],"weight":1,"_version_":1666802845624565760,"score":76.33811},{"pmid":32371560,"title":"PAP therapy increases the risk of transmission of COVID-19.","text":["PAP therapy increases the risk of transmission of COVID-19.","Positive airway pressure (PAP) therapy is an open system that can generate contact, droplet, and airborne COVID-19 thereby increasing the risk of transmission of COVID-19 like other procedures such as tracheal intubation, noninvasive ventilation, and cardiopulmonary resuscitation. Medically prudent recommendations have been established for home use of PAP therapy in asymptomatic patients and patients with suspected or confirmed COVID-19. Recommendations for sleep clinics and sleep laboratory activities are also discussed as well as the emergency use of PAP devices as a substitute for ventilation.","Cleve Clin J Med","Lance, Colleen G","32371560"],"abstract":["Positive airway pressure (PAP) therapy is an open system that can generate contact, droplet, and airborne COVID-19 thereby increasing the risk of transmission of COVID-19 like other procedures such as tracheal intubation, noninvasive ventilation, and cardiopulmonary resuscitation. Medically prudent recommendations have been established for home use of PAP therapy in asymptomatic patients and patients with suspected or confirmed COVID-19. Recommendations for sleep clinics and sleep laboratory activities are also discussed as well as the emergency use of PAP devices as a substitute for ventilation."],"journal":"Cleve Clin J Med","authors":["Lance, Colleen G"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32371560","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3949/ccjm.87a.ccc003","topics":["Prevention","Transmission"],"weight":1,"_version_":1666138496388038657,"score":58.53267},{"pmid":32428084,"title":"Speech therapy, breastfeeding and COVID-19: information to speech therapist.","text":["Speech therapy, breastfeeding and COVID-19: information to speech therapist.","Codas","Miranda, Vanessa Souza Gigoski de","Rech, Rafaela Soares","Maahs, Marcia Angelica Peter","Berbert, Monalise Costa Batista","Almeida, Sheila Tamanini de","32428084"],"journal":"Codas","authors":["Miranda, Vanessa Souza Gigoski de","Rech, Rafaela Soares","Maahs, Marcia Angelica Peter","Berbert, Monalise Costa Batista","Almeida, Sheila Tamanini de"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32428084","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1590/2317-1782/20192020124","weight":0,"_version_":1667252837848973312,"score":57.11402},{"pmid":32393409,"title":"Does intranasal naloxone administration increase the risk of COVID-19 transmission?","text":["Does intranasal naloxone administration increase the risk of COVID-19 transmission?","CJEM","Leong, Yuen Chin","Verbeek, P Richard","32393409"],"journal":"CJEM","authors":["Leong, Yuen Chin","Verbeek, P Richard"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32393409","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1017/cem.2020.395","e_drugs":["Naloxone"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1666627827926040576,"score":57.060272},{"pmid":32156331,"pmcid":"PMC7068166","title":"Updated rapid risk assessment from ECDC on the outbreak of COVID-19: increased transmission globally.","text":["Updated rapid risk assessment from ECDC on the outbreak of COVID-19: increased transmission globally.","Euro Surveill","Eurosurveillance Editorial Team","32156331"],"journal":"Euro Surveill","authors":["Eurosurveillance Editorial Team"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32156331","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.2807/1560-7917.ES.2020.25.9.2003051","topics":["Prevention","Transmission"],"weight":1,"_version_":1666138492684468225,"score":53.43132}]}